Chris Murphy actually said...
I know this is an issue that doesn't necessarily fit natural to Congress to be funding physician and provider education, but we're talking about next year reports suggesting that 8 of the top 10 drugs on the market are going to be biosimilars.
Context
Senator Murphy discusses the need for funding education on biosimilars amidst rising drug costs.
09/16/2015